|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Epilepsy | |||||
| 2 | More general conditions related to this trial | ||||
| Brain Diseases | |||||
| Central Nervous System Diseases | |||||
| Nervous System Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| phenytoin | |||||
| phenytoin and probenecid | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Probenecid | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anticonvulsants | |||||
| Antirheumatic Agents | |||||
| Central Nervous System Agents | |||||
| Gout Suppressants | |||||
| Pharmacologic Actions | |||||
| Renal Agents | |||||
| Therapeutic Uses | |||||
| Uricosuric Agents | |||||
| 6 | Sponsors listed in this trial | ||||
| Ohio State University | |||||